Search | IOVS | ARVO Journals

Showing 1 – 20 of 87

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina February 2025

Topography of Slowed Dark Adaptation in Pseudoxanthoma Elasticum: PROPXE Study Report 1

PDF

Kristina Pfau; Georg Ansari; Stephan Michels; Chantal Dysli; Sandra Liakopoulos; Jana Burghaus-Zhang; Mayss Al-Sheikh; Justus G. Garweg; Mathieu Quinodoz; Karolina Kaminska; Francesca Cancellieri; Carlo Rivolta; Sharon F. Terry; Nicolas Feltgen; Maximilian Pfau
TAGS: dark adaptation, pseudoxanthoma elasticum, study report, rod photoreceptors, calcification, retinal cone
Invest. Ophthalmol. Vis. Sci.. 2025; 66(2):17. https://doi.org/10.1167/iovs.66.2.17

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Contrast sensitivity function using a prototype gaze tracking-based virtual reality headset in age-related macular degeneration (AMD)

Deepayan Kar; Alex McKeown; Stephan Michels; Nicola Grüninger; Stephan Wyder; Matthias Pfister; Lukas Scheibler

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1483.

ARVO Annual Meeting Abstract June 2024

Impact of Visual Function on Vision-Related Quality of Life in Pseudoxanthoma Elasticum

Sophie-Christin Kornelia Ernst; Kristina Pfau; Georg Ansari; Stephan Michels; Hendrik P Scholl; Maximilian Pfau

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5967.

ARVO Annual Meeting Abstract June 2022

A 10-Year Review of Management of Ocular Mucous Membrane Pemphigoid: A Private Practice Experience

Kasey Johnson; James T Rosenbaum; Jason T Yarter; Talmage Broadbent; Kevin S Michels

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):896 – A0260.

ARVO Annual Meeting Abstract July 2019

Intravitreal Aflibercept in a Routine Treat and Extend (T&E) Regimen for Treatment-Naïve wet AMD Patients: 2-Year Outcomes of the observational ASTERIA Study

Andreas Ebneter; Stephan Michels; Pascal Imesch; Felix Eilenberger; Susanne Oesch; Christian Prünte; Katja Hatz

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):95.

ARVO Annual Meeting Abstract July 2019

Influence of Vitrectomy and Maculapeeling on Abnormalities of the Central Foveal Bouquet in eyes with Epiretinal Membranes

Max Brinkmann; Carolin Saljé; Matthias Becker; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5763.

ARVO Annual Meeting Abstract September 2016

Effect of long-term anti-VEGF treatment on the retinal microarchitecture of patients with diabetic macular edema

Magdalena Anna Wirth; Matthias D Becker; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2067.

ARVO Annual Meeting Abstract June 2015

Effect of intravitreal aflibercept in prior treated patients with persistent diabetic macular edema

Florentina Joyce Freiberg; Matthias Becker; Nicole Tracy Graf Johansen; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4624.

ARVO Annual Meeting Abstract June 2015

Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in Central Retinal Vein Occlusion (CRVO): 1 year results

Maximilian Pfau; Heidi Fassnacht-Riederle; Matthias Becker; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4625.

ARVO Annual Meeting Abstract June 2015

Clinical experience with the first commercially available intraoperative optical coherence tomography system (iOCT)

Matthias D Becker; Maximilian Pfau; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5909.

ARVO Annual Meeting Abstract June 2013

No IOP-Elevation in patients treated with Anti-VEGF ranibizumab for diabetic macular edema

Peter Ciechanowski; Marc Stahel; Frank Moser; Sandra Lortz; Heidi Fassnacht; Nicole Graf; Stephan Estermann; Matthias Becker; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2407.

ARVO Annual Meeting Abstract June 2013

Visual acuity evaluation in patients treated with ranibizumab for diabetic macular edema

Marc Stahel; Peter Ciechanowski; Frank Moser; Sandra Lortz; Heidi Fassnacht; Nicole Graf; Matthias Becker; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4927.

ARVO Annual Meeting Abstract March 2012

Effect of Combined Topical Heparin and Steroid on Corneal Neovascularization in Children

Stephan Michels; Stephan L. Kaminski; Rike Michels

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2955.

ARVO Annual Meeting Abstract March 2012

Intracorneal Bevacizumab (Avastin®) For The Treatment of Corneal Neovascularization

Stephan L. Kaminski; Isabella Baumgartner; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2956.

ARVO Annual Meeting Abstract March 2012

Intravitreal Anti-VEGF Therapy For Retinal Macroaneurysm

Sandrine A. Zweifel; Magdalena Toenz; Lukas Pfenninger; Matthias D. Becker; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):966.

Genetics June 2011

Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD

PDF

Barbara Kloeckener-Gruissem; Daniel Barthelmes; Stephan Labs; Christian Schindler; Malaika Kurz-Levin; Stephan Michels; Johannes Fleischhauer; Wolfgang Berger; Florian Sutter; Moreno Menghini
TAGS: exudative age-related macular degeneration, genetics, ranibizumab, single nucleotide polymorphism, genotype, genetic aspects
Invest. Ophthalmol. Vis. Sci.. 2011; 52(7):4694-4702. https://doi.org/10.1167/iovs.10-6080

ARVO Annual Meeting Abstract April 2011

Status Of Posterior Vitreus Detachement In Full Thickness Macular Holes And Macular Pucker. Correlation Of OCT And In-vivo Clinical Findings. Do We Judge Right?

Matthias D. Becker; Magdalena Toenz; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4488.

ARVO Annual Meeting Abstract April 2011

Multimodal Imaging of Drusen Associated with Malattia Leventinese

Sandrine A. Zweifel; Patrizia Tschuor; Istvan Magyar; Wolfgang Berger; Matthias Becker; Christina Springer; Stephan Michels

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3703.

ARVO Annual Meeting Abstract April 2011

Influence of a Loading Phase on Long-term Visual Acuity with Respect to Genetic and Clinical Factors in Patients with Neovascular Age-related Macular Degeneration

Moreno Menghini; Florian K. Sutter; Barbara Kloeckener-Gruissem; Johannes C. Fleischhauer; Malaika M. Kurz; Sandrine A. Zweifel; Stephan Michels; Wolfgang Berger; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5243.

ARVO Annual Meeting Abstract April 2011

A Swiss Patient Cohort Reveals Genetic Predisposition Of Known And New Genetic Loci To AMD And To Intravitreal Ranibizumab (lucentis®) Treatment Outcome

Barbara Kloeckener-Gruissem; Moreno Menghini; Daniel Barthelmes; Stephan Labs; Malaika Kurz-Levin; Stephan Michels; Johannes Fleischhauer; Florian Sutter; Wolfgang Berger

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5249.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Topography of Slowed Dark Adaptation in Pseudoxanthoma Elasticum: PROPXE Study Report 1

Contrast sensitivity function using a prototype gaze tracking-based virtual reality headset in age-related macular degeneration (AMD)

Impact of Visual Function on Vision-Related Quality of Life in Pseudoxanthoma Elasticum

A 10-Year Review of Management of Ocular Mucous Membrane Pemphigoid: A Private Practice Experience

Intravitreal Aflibercept in a Routine Treat and Extend (T&E) Regimen for Treatment-Naïve wet AMD Patients: 2-Year Outcomes of the observational ASTERIA Study

Influence of Vitrectomy and Maculapeeling on Abnormalities of the Central Foveal Bouquet in eyes with Epiretinal Membranes

Effect of long-term anti-VEGF treatment on the retinal microarchitecture of patients with diabetic macular edema

Effect of intravitreal aflibercept in prior treated patients with persistent diabetic macular edema

Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in Central Retinal Vein Occlusion (CRVO): 1 year results

Clinical experience with the first commercially available intraoperative optical coherence tomography system (iOCT)

No IOP-Elevation in patients treated with Anti-VEGF ranibizumab for diabetic macular edema

Visual acuity evaluation in patients treated with ranibizumab for diabetic macular edema

Effect of Combined Topical Heparin and Steroid on Corneal Neovascularization in Children

Intracorneal Bevacizumab (Avastin®) For The Treatment of Corneal Neovascularization

Intravitreal Anti-VEGF Therapy For Retinal Macroaneurysm

Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD

Status Of Posterior Vitreus Detachement In Full Thickness Macular Holes And Macular Pucker. Correlation Of OCT And In-vivo Clinical Findings. Do We Judge Right?

Multimodal Imaging of Drusen Associated with Malattia Leventinese

Influence of a Loading Phase on Long-term Visual Acuity with Respect to Genetic and Clinical Factors in Patients with Neovascular Age-related Macular Degeneration

A Swiss Patient Cohort Reveals Genetic Predisposition Of Known And New Genetic Loci To AMD And To Intravitreal Ranibizumab (lucentis®) Treatment Outcome

To View More...

You must be signed into an individual account to use this feature.